Comparison of two doses of recombinant VIIA (rFVIIA) for producing hemostasis during and after surgery in patients with hemophilia A or B and inhibitors and patients with acquired inhibitors.

被引：0
|
作者：
Cooper, HA
Gilchrist, GS
Hoots, WK
Shapiro, A
机构：
[1] UNC HOSP,CHAPEL HILL,NC
[2] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905
[3] INDIANA UNIV,INDIANAPOLIS,IN 46204
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2665 / 2665
页数：1
相关论文
共 50 条
  • [21] The Comparison of Hemostatic Effects of Recombinant Activated Factor VII (rFVIIa) in Thrombocytopenic Patients (pts) and Hemophilia Pts with Inhibitors
    Galstian, Gennadii M.
    Kolosova, Irina V.
    Gemdzhian, Eduard
    Zorenko, Vladimir Yu.
    Polyanskaya, Tatyana A.
    Orel, Elena B.
    Savchenko, Valeri G.
    BLOOD, 2015, 126 (23)
  • [22] HIGHER DOSES OF RECOMBINANT FACTOR VIIA (RFVIIA) ≥250 MCG/KG IN PEDIATRIC PATIENTS WITH CONGENITAL HEMOPHILIA COMPLICATED BY INHIBITORS: THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY REGISTRY EXPERIENCE (2004-2008)
    Neufeld, Ellis J.
    Kessler, Craig M.
    Gill, Joan Cox
    Wilke, Caitlyn
    Cooper, David L.
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 710 - 710
  • [23] A COMPARISON OF DOSING OF RECOMBINANT FACTOR VIIa (rFVIIa) IN PEDIATRIC VERSUS ADULT PATIENTS WITH CONGENITAL HEMOPHILIA WITH INHIBITORS (CHwI): PRESCRIPTION AND ACTUAL DATA FROM THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA (DOSE)
    Gruppo, Ralph
    Kessler, Craig
    Neufeld, Ellis
    Cooper, David
    Carr, Marcus
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 810 - 810
  • [24] Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa
    Ingerslev, J
    Freidman, D
    Gastineau, D
    Gilchrist, G
    Johnsson, H
    Lucas, G
    McPherson, J
    Preston, E
    Scheibel, E
    Shuman, M
    HAEMOSTASIS, 1996, 26 : 118 - 123
  • [25] Surgical Experience with Recombinant FVIIa (rFVIIa) in Patients with Hemophilia and Inhibitors to Factors VIII or IX.
    Valentino, Leonard A.
    Cooper, David L.
    BLOOD, 2009, 114 (22) : 534 - 534
  • [26] SUCCESSFUL PERIOPERATIVE HEMOSTASIS USE OF RFVIIA IN MAJOR ORTHOPEDIC SURGERY IN A SEVERE HEMOPHILIA B PATIENT WITH INHIBITORS ON CONCIZUMAB PROPHYLAXIS
    Jimenez Yuste, V.
    Fernandez Bello, I.
    Martin-Salces, M.
    Rivas, I.
    Garcia-Barcenilla, S.
    Cebanu, T.
    Butta, N.
    Alvarez-Roman, M. T.
    HAEMOPHILIA, 2020, 26 : 129 - 129
  • [27] Recombinant FVIIa (rFVIIa) use for surgery in congenital hemophilia with inhibitors (CHWI) patients: data from the hemophilia and thrombosis research society (HTRS) registry
    Neufeld, E.
    Saxena, K.
    Cooper, D. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 472 - 472
  • [28] Safety of higher doses of recombinant factor VIIa (rFVIIa) ≥ 250 mcg/kg in patients with congenital hemophilia complicated by inhibitors (CHwI): the hemophilia and thrombosis research society (HTRS) registry experience (2004-2008)
    Neufeld, E. J.
    Kessler, C. M.
    Gill, J. C.
    Wilke, C. T.
    Cooper, D. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 523 - 523
  • [29] Primary knee arthroplasty using recombinant factor VIIa (rFVIIa) as first-line therapy in hemophilia patients with high responding inhibitors: the Eureka study
    Laurian, Y.
    Solimeno, L. P.
    Nunez, R.
    Kurth, A.
    Molina, V.
    Jimenez-Juste, V.
    Goddard, N.
    Santagostino, E.
    Tagariello, G.
    Morfini, M.
    HAEMOPHILIA, 2008, 14 (02) : 400 - 401
  • [30] Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors
    Konkle, B. A.
    Ebbesen, L. S.
    Erhardtsen, E.
    Bianco, R. P.
    Lissitchkov, T.
    Rusen, L.
    Serban, M. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (09) : 1904 - 1913
12345